Search

Layla D. Berry

Examiner (ID: 16889, Phone: (571)272-9572 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1673, 1609, 1623, 1693
Total Applications
1713
Issued Applications
1092
Pending Applications
106
Abandoned Applications
561

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17385576 [patent_doc_number] => 20220033428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => LARGE SCALE PREPARATION OF PSEUDO-TRISACCHARIDE AMINOGLYCOSIDES AND OF INTERMEDIATES THEREOF [patent_app_type] => utility [patent_app_number] => 17/493672 [patent_app_country] => US [patent_app_date] => 2021-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24249 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493672 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/493672
LARGE SCALE PREPARATION OF PSEUDO-TRISACCHARIDE AMINOGLYCOSIDES AND OF INTERMEDIATES THEREOF Oct 3, 2021 Abandoned
Array ( [id] => 18784836 [patent_doc_number] => 20230372492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => DRUGS CONJUGATED WITH HEXOSE PHOSPHATE AND METHODS OF MAKING AND USING SAME [patent_app_type] => utility [patent_app_number] => 18/247049 [patent_app_country] => US [patent_app_date] => 2021-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6563 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247049 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/247049
DRUGS CONJUGATED WITH HEXOSE PHOSPHATE AND METHODS OF MAKING AND USING SAME Sep 28, 2021 Pending
Array ( [id] => 19150126 [patent_doc_number] => 11975016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-07 [patent_title] => 2'-substituted-N [patent_app_type] => utility [patent_app_number] => 17/482224 [patent_app_country] => US [patent_app_date] => 2021-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34801 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482224 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/482224
2'-substituted-N Sep 21, 2021 Issued
Array ( [id] => 17704957 [patent_doc_number] => 20220204963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF [patent_app_type] => utility [patent_app_number] => 17/472367 [patent_app_country] => US [patent_app_date] => 2021-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9478 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472367 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/472367
OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF Sep 9, 2021 Abandoned
Array ( [id] => 19001974 [patent_doc_number] => 20240066045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-29 [patent_title] => SEMICARBAZONE-BASED SAPONIN CONJUGATE [patent_app_type] => utility [patent_app_number] => 18/044950 [patent_app_country] => US [patent_app_date] => 2021-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50184 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -72 [patent_words_short_claim] => 256 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044950 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/044950
SEMICARBAZONE-BASED SAPONIN CONJUGATE Sep 8, 2021 Pending
Array ( [id] => 18675287 [patent_doc_number] => 20230312887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => PROCESS FOR PREPARING SUGAMMADEX [patent_app_type] => utility [patent_app_number] => 18/022570 [patent_app_country] => US [patent_app_date] => 2021-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10727 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022570 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/022570
PROCESS FOR PREPARING SUGAMMADEX Sep 7, 2021 Pending
Array ( [id] => 17312824 [patent_doc_number] => 20210401872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => HyperOsmolar Composition of Hyaluronic Acid [patent_app_type] => utility [patent_app_number] => 17/467918 [patent_app_country] => US [patent_app_date] => 2021-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2987 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17467918 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/467918
Hyperosmolar composition of hyaluronic acid Sep 6, 2021 Issued
Array ( [id] => 17563152 [patent_doc_number] => 20220127301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => ASYMMETRIC AUXILIARY GROUP [patent_app_type] => utility [patent_app_number] => 17/465238 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14251 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465238 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/465238
ASYMMETRIC AUXILIARY GROUP Sep 1, 2021 Pending
Array ( [id] => 19032467 [patent_doc_number] => 20240082282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => Hygromycin A Compositions and Methods of Use [patent_app_type] => utility [patent_app_number] => 18/042741 [patent_app_country] => US [patent_app_date] => 2021-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22523 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042741 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/042741
Hygromycin A Compositions and Methods of Use Aug 31, 2021 Pending
Array ( [id] => 17460611 [patent_doc_number] => 20220073916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => NOVEL PHOSPHORAMIDITES [patent_app_type] => utility [patent_app_number] => 17/405708 [patent_app_country] => US [patent_app_date] => 2021-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23089 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405708 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/405708
NOVEL PHOSPHORAMIDITES Aug 17, 2021 Pending
Array ( [id] => 18716556 [patent_doc_number] => 11793879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => Monolithic composition for dual-rate release with high drug loading [patent_app_type] => utility [patent_app_number] => 17/405610 [patent_app_country] => US [patent_app_date] => 2021-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5682 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405610 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/405610
Monolithic composition for dual-rate release with high drug loading Aug 17, 2021 Issued
Array ( [id] => 17314453 [patent_doc_number] => 20210403501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => COMPOSITIONS AND METHODS OF MODULATING THE IMMUNE RESPONSE BY ACTIVATING ALPHA PROTEIN KINASE 1 [patent_app_type] => utility [patent_app_number] => 17/445113 [patent_app_country] => US [patent_app_date] => 2021-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42494 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445113 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/445113
Compositions and methods of modulating the immune response by activating alpha protein kinase 1 Aug 15, 2021 Issued
Array ( [id] => 18825281 [patent_doc_number] => 11840551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-12 [patent_title] => Compositions and methods of modulating the immune response by activating alpha protein kinase 1 [patent_app_type] => utility [patent_app_number] => 17/445122 [patent_app_country] => US [patent_app_date] => 2021-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 57 [patent_no_of_words] => 42545 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445122 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/445122
Compositions and methods of modulating the immune response by activating alpha protein kinase 1 Aug 15, 2021 Issued
Array ( [id] => 17383845 [patent_doc_number] => 20220031697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => Dose and regimen for an hdm2-p53 interaction inhibitor in hematological tumors [patent_app_type] => utility [patent_app_number] => 17/401600 [patent_app_country] => US [patent_app_date] => 2021-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6809 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401600 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/401600
Dose and regimen for an hdm2-p53 interaction inhibitor in hematological tumors Aug 12, 2021 Abandoned
Array ( [id] => 18753952 [patent_doc_number] => 20230357303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B [patent_app_type] => utility [patent_app_number] => 18/020119 [patent_app_country] => US [patent_app_date] => 2021-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020119 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/020119
HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B Aug 8, 2021 Pending
Array ( [id] => 17734687 [patent_doc_number] => 20220220146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => MORPHIC FORMS OF 4-AMINO-7-(3,4-DIHYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2-METHYL-7H-PYRROLO[2,3-d]PYRIMIDINE-5-CARBOXAMIDE AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/393496 [patent_app_country] => US [patent_app_date] => 2021-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44312 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17393496 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/393496
MORPHIC FORMS OF 4-AMINO-7-(3,4-DIHYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2-METHYL-7H-PYRROLO[2,3-d]PYRIMIDINE-5-CARBOXAMIDE AND USES THEREOF Aug 3, 2021 Abandoned
Array ( [id] => 19890371 [patent_doc_number] => 20250115683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-10 [patent_title] => METHOD OF EXTRACTION OF A GALACTOMANNAN GUM FROM ALFALFA SEEDS [patent_app_type] => utility [patent_app_number] => 18/164983 [patent_app_country] => US [patent_app_date] => 2021-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10775 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18164983 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/164983
METHOD OF EXTRACTION OF A GALACTOMANNAN GUM FROM ALFALFA SEEDS Aug 2, 2021 Issued
Array ( [id] => 19890371 [patent_doc_number] => 20250115683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-10 [patent_title] => METHOD OF EXTRACTION OF A GALACTOMANNAN GUM FROM ALFALFA SEEDS [patent_app_type] => utility [patent_app_number] => 18/164983 [patent_app_country] => US [patent_app_date] => 2021-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10775 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18164983 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/164983
METHOD OF EXTRACTION OF A GALACTOMANNAN GUM FROM ALFALFA SEEDS Aug 2, 2021 Issued
Array ( [id] => 18871168 [patent_doc_number] => 11858954 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid [patent_app_type] => utility [patent_app_number] => 17/392970 [patent_app_country] => US [patent_app_date] => 2021-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 30 [patent_no_of_words] => 27256 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392970 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/392970
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid Aug 2, 2021 Issued
Array ( [id] => 17687686 [patent_doc_number] => 20220194978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => PROCESS FOR THE MANUFACTURE OF (2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(((4AR,10AR)-7-HYDROXY-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO[G]QUINOLIN-6-YL)OXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID [patent_app_type] => utility [patent_app_number] => 17/391439 [patent_app_country] => US [patent_app_date] => 2021-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17997 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17391439 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/391439
Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid Aug 1, 2021 Issued
Menu